Amgen Patents for Cholesterol Drug Repatha Upheld by Jury  Bloomberg

Amgen Inc. beat back a challenge from Sanofi and Regeneron Pharmaceuticals Inc. as a U.S. jury upheld two patents for its Repatha, which treats extremely …